Saturday 17 October 2026 Export TARS’s income statement to Excel — free account

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $451.4 million, up 146.7% from fiscal 2024. In the quarter to June 2026, revenue grew 69.4%, EPS grew 10.4%, free cash flow grew 288.1% and total debt was flat, each against the same quarter a year earlier.

68.07 2.92 −4.11%

Follow TARS

Alert me

Market cap: $3.5B
P/E: 0.0×
Fwd P/E: −92.6×
Dividend yield: —
F-score: 5/9
Altman Z: 9.54
Beneish M: −1.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	5	5
ROE Full definition →		(28.35%)	(23.39%)	(13.96%)	(13.68%)
ROA Full definition →		(17.82%)	(14.14%)	(8.92%)	(8.40%)
ROIC Full definition →		(988.67%)	0.00%	(96.77%)	0.00%
Return on Tangible Assets Full definition →		(20.79%)	(16.66%)	(11.73%)	(11.43%)
Average Days of Receivables Full definition →		74.11	70.44	79.95	59.18
Free Cash Flow per Share Full definition →		(1.35)	(0.53)	(0.73)	1.29
Free Cash Flow Full definition →		(57.54)	(22.31)	(31.54)	56.00
Capital Expenditures Full definition →		(3.57)	(9.86)	(15.09)	(18.15)
Other line items
Cash ROIC Full definition →		(7.11%)	(2.68%)	(3.89%)	6.44%
Accounts Receivable Turnover Full definition →		7.00	6.68	5.90	7.65
Accounts Payable Turnover Full definition →		0.31	2.38	0.69	0.69
Inventory Turnover Full definition →		7.39	8.78	9.58	9.88
Average Days of Payables Full definition →		1,530.48	194.93	252.60	359.59
Days of Inventory on Hand Full definition →		56.72	52.01	47.86	39.21
Tax Rate Full definition →		0.00	0.00	0.05	0.13
Research and Development Expense of Revenue Full definition →		17.25%	14.25%	13.51%	14.46%
Selling, General and Administrative Expense of Revenue Full definition →		99.88%	94.67%	89.47%	86.82%
Share Based Compensation of Revenue Full definition →		9.51%	9.24%	8.74%	8.55%
Interest Coverage Full definition →		(9.68)	(7.94)	(5.74)	(5.54)
Operating CF/Net income Full definition →		0.66	0.19	0.34	(1.60)
Depreciation/Fixed assets Full definition →		(0.64)	(0.26)	(0.15)	(0.05)
Capex/Depreciation Full definition →		0.98	3.21	5.78	16.55
Revenue per Share Full definition →		8.59	10.80	12.46	13.97
Operating CF per Share Full definition →		(1.27)	(0.30)	(0.38)	1.71
Capex per Share Full definition →		(0.08)	(0.24)	(0.35)	(0.42)
Capex to Sales Full definition →		0.01	0.02	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly